78.98MMarket Cap-1.58P/E (TTM)
5.150High4.820Low50.56KVolume5.000Open4.999Pre Close250.59KTurnover0.63%Turnover RatioLossP/E (Static)16.02MShares9.44052wk High-27.09P/B39.52MFloat Cap4.66052wk Low--Dividend TTM8.02MShs Float9.440Historical High--Div YieldTTM6.60%Amplitude4.660Historical Low4.955Avg Price1Lot Size
Alpha Cognition Stock Forum
Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury
December 11, 2024 08:30 AM Eastern Standard Time
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders, today announced inte...
No comment yet